Muscle Quality Predicts Outcomes After Surgery for Early-Stage Non-Small-Cell Lung Cancer
Overview
Affiliations
Purpose: This study investigated the impact of skeletal muscle quality on the outcomes of patients undergoing surgery for early-stage non-small-cell lung cancer (NSCLC).
Methods: A total of 98 patients with pathological stage I-II NSCLC who underwent lobectomy or segmentectomy were retrospectively analyzed. Along with skeletal muscle quantity, muscle quality was evaluated by intramuscular adipose tissue content (IMAC) at the first lumbar vertebral level; a higher IMAC indicates lower skeletal muscle quality. Patients were divided into two groups according to the gender-specific quartiles of IMAC, and the prognostic impact of IMAC was investigated.
Results: No significant differences in the body and skeletal mass indices, which indicate skeletal muscle quantity, were observed between patients with high and those with normal IMAC. Patients with high IMAC (n = 23) showed a significantly poorer prognosis in overall and disease-specific survivals than those with normal IMAC (n = 75; P <0.001 and P = 0.048, respectively). In a bivariate analysis that included other clinicopathological factors, a high IMAC was independently associated with worse overall survival.
Conclusion: The skeletal muscle quality evaluated by IMAC could be used to predict survival risk after surgery for early-stage NSCLC.
Liu R, Qiu Z, Zhang L, Ma W, Zi L, Wang K J Cachexia Sarcopenia Muscle. 2023; 14(6):2509-2519.
PMID: 37990969 PMC: 10751448. DOI: 10.1002/jcsm.13371.
Impact of body composition on patient prognosis after SARS-Cov-2 infection.
Yamamoto T, Sugimoto K, Ichikawa S, Suzuki K, Wakabayashi H, Dohi K PLoS One. 2023; 18(7):e0289206.
PMID: 37506083 PMC: 10381082. DOI: 10.1371/journal.pone.0289206.
Fairfield W, Minton D, Elliehausen C, Nichol A, Cook T, Rathmacher J Nutrients. 2022; 14(21).
PMID: 36364934 PMC: 9658601. DOI: 10.3390/nu14214674.